News

Read the story about PharmNovo and our drug candidate PN6047 for neurophatic pain and its ongoing phase I studies in Svenska Dagbladet.

PharmNovo appoints CFO and Clinical lead to strengthen the organization.

We are pleased to inform that during the summer, the application to start

We are pleased to announce that we have raised 67 MSEK in a new share issue led by Sciety.

The Clinical Trial Application (CTA) has been submitted to the MPA

It is with pleasure that we can announce that Clinical Trial Consultants AB (CTC)